| Dr Daniel Ryan Latta, MD | |
|
1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 | |
| (610) 482-8000 | |
| Not Available |
| Full Name | Dr Daniel Ryan Latta |
|---|---|
| Gender | Male |
| Speciality | Colorectal Surgery (proctology) |
| Experience | 11 Years |
| Location | 1200 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023456852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MT204239 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand View Home Care | Sellersville, PA | Home health agency |
| Grand View Hospital | Sellersville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grand View Hospital | 8022001924 | 135 |
News Archive
Researchers at the University of North Carolina at Chapel Hill have discovered a genetic risk factor for severe liver disease in people with cystic fibrosis. Those who carry a particular variant of the SERPINA1 gene (also known as alpha-1-antitrypsin or alpha-1-antiprotease) are five times more likely to develop cirrhosis and other liver complications than patients who carry the normal version of the gene.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
Medical schools are changing to adapt to the shifting medical landscape around America by increasingly preparing students for alternative methods of care, increased demand for their services and a world where health care reform will likely soon change the landscape again, The Washington Post reports.
Manipulating a group of hormone-producing cells in the brain can control blood sugar levels in the body - a discovery that has dramatic potential for research into weight-loss drugs and diabetes treatment.
› Verified 7 days ago
| Entity Name | Grand View Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1821286097 PECOS PAC ID: 8022001924 Enrollment ID: O20080522000278 |
News Archive
Researchers at the University of North Carolina at Chapel Hill have discovered a genetic risk factor for severe liver disease in people with cystic fibrosis. Those who carry a particular variant of the SERPINA1 gene (also known as alpha-1-antitrypsin or alpha-1-antiprotease) are five times more likely to develop cirrhosis and other liver complications than patients who carry the normal version of the gene.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
Medical schools are changing to adapt to the shifting medical landscape around America by increasingly preparing students for alternative methods of care, increased demand for their services and a world where health care reform will likely soon change the landscape again, The Washington Post reports.
Manipulating a group of hormone-producing cells in the brain can control blood sugar levels in the body - a discovery that has dramatic potential for research into weight-loss drugs and diabetes treatment.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Ryan Latta, MD 1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 Ph: (610) 482-8000 | Dr Daniel Ryan Latta, MD 1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 Ph: (610) 482-8000 |
News Archive
Researchers at the University of North Carolina at Chapel Hill have discovered a genetic risk factor for severe liver disease in people with cystic fibrosis. Those who carry a particular variant of the SERPINA1 gene (also known as alpha-1-antitrypsin or alpha-1-antiprotease) are five times more likely to develop cirrhosis and other liver complications than patients who carry the normal version of the gene.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
Medical schools are changing to adapt to the shifting medical landscape around America by increasingly preparing students for alternative methods of care, increased demand for their services and a world where health care reform will likely soon change the landscape again, The Washington Post reports.
Manipulating a group of hormone-producing cells in the brain can control blood sugar levels in the body - a discovery that has dramatic potential for research into weight-loss drugs and diabetes treatment.
› Verified 7 days ago
Robert D Barraco, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Suite 308, Allentown, PA 18103 Phone: 610-402-1350 Fax: 610-402-1356 | |
Rovinder Singh Sandhu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-1350 | |
Heiwon Chung, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-7884 | |
Heather Lynn Geist, MD Surgery Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Dr. Marissa Lynn Dallara, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
William D Hardin Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1259 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-1259 |